Seborrheic dermatitis: An update

Acta Dermatovenerologica Croatica

Volumn 20, Issue 2, 2012, Pages 98-104

  Mokos, Zrinka Bukvić ^a   Kralj, Martina ^b   Basta Juzbašić, Aleksandra ^a   Jukić, Ines Lakoš ^a  

^a KBC Zagreb   (Croatia)

^b KARLOVAC GENERAL HOSPITAL   (Croatia)

Author keywords

Antifungal agents; Malassezia yeast; Seborrheic dermatitis; Sebum

Indexed keywords

ANTIFUNGAL AGENT; BIFONAZOLE; CALCINEURIN INHIBITOR; CICLOPIROX; CORTICOSTEROID; FLUCONAZOLE; HYDROCORTISONE; HYDROCORTISONE ACETATE; KETOCONAZOLE; LEVODOPA; LITHIUM GLUCONATE; LITHIUM SALT; METRONIDAZOLE; MICONAZOLE; PIMECROLIMUS; PLACEBO; PYRITHIONE ZINC; SELENIUM SULFIDE; SKIN LIPID; SUCCINATE LITHIUM; TACROLIMUS; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ATROPHY; CLINICAL FEATURE; CREAM; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FUNGAL VIRULENCE; HUMAN; HYPERTRICHOSIS; IMMUNOPATHOGENESIS; LYMPHOMA; MALASSEZIA; MALASSEZIA FURFUR; MALASSEZIA GLOBOSA; MALASSEZIA OBOBTUSA; MALASSEZIA RESTRICTA; MALASSEZIA SLOOFFIAE; MALASSEZIA SYMPODIALIS; NONHUMAN; OUTCOME ASSESSMENT; PERIORAL DERMATITIS; PHOTOTHERAPY; REVIEW; SEBACEOUS GLAND; SEBORRHEA; SEBORRHEIC DERMATITIS; SEBUM SECRETION; SINGLE DRUG DOSE; SKIN BIOPSY; SKIN CARE; SKIN DISEASE; TELANGIECTASIA;

ANTIFUNGAL AGENTS; CALCINEURIN; COMORBIDITY; DERMATITIS, SEBORRHEIC; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALASSEZIA; PARKINSON DISEASE; PHOTOTHERAPY; SEBUM;

EID: 84862835589     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Stefanaki I, Katsambas A. Therapeutic update on sebborheic dermatitis. Skin Ther Lett 2010;15:1-4.
2. Fritsch PO, Reider N. Other eczematous eruptions. In: Bologna JL, Jorizzo JL, Rapini R P, editors. Dermatology. New York: Mosby; 2003. pp. 215-218.
3. Picardo M, Camelli N. Seborrheic dermatitis. In: Williams H, editor. Evidence-Based Dermatology. Blackwell Publishing; 2008. pp. 164-170.
4. Gupta AK, Bluhm R, Cooper EA, Summerbell RC, Batra R. Seborrheic dermatitis. Dermatol Clin 2003;21:401-412.
5. Del Rosso JQ, Kim GK. Seborrheic dermatitis and Malassezia species: how are they related? J Clin Aesth Dermatol 2009;111:14-17.
6. Janniger CK, Shwartz RA. Seborrheic dermatitis. Am Fam Physician 1995;52:149-155, 159-160.
7. Beiber T. Other types of dermatitis. In: Burgdorf WHC, Plewig G, Wolf HH, Landhalter M, editors. Braun Falco's Dermatology. Springer; 2009. pp. 425-433.
8. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL. Skin disease associated with Malassezia species. J Am Acad Dermatol 2004;54:785-798.
9. Nakabayashi A, Sei Y, Gulliot J. Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, pity-riasis versicolor and normal subjects. Med Mycol 2000;38:337-341.
10. Dawson TL. Malassezia globosa and restricta: breakthrough understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis. J Invest Der-matol 2007;12:15-19.
11. Greaves MV, Camp RDR. Prostaglandins, leukotrienes, phospholipase, platelet activating factor and cytokines: an integrated approach to inflammation of human skin. Arch Dermatol Res 1988;280:S33-S41.
12. Riciputo RM, Oliveri S, Micali G, Sapuppo A. Phospholipase activity in Malassezia furfur pathogenic strains. Mycoses 1996;39:233-235.
13. Naldi L, Rebora A. Seborrheic dermatitis. N Engl J Med 2009;360:387-396.
14. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004;18:13-26.
15. Bergbrant IM, Johansson S, Robbins D, Scheynius A, Faergemann J, Södeström T. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol 1991;16:331-338.
16. Faergemann J, Bergbrant IM, Dohsé M. Seborr-hoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohisto-chemistry. Br J Dermatol 2001;144:549-556.
17. Cowley NC, Farr RM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol 1990;122:71-76.
18. Burton JL, Shuster S. Effect of L-dopa on seborr-hoea of parkinsonism. Lancet 1970;2:19-20.
19. Burton JL, Cartlidge M, Shuster S. Effect of L-dopa on the seborrhoea of parkinsonism. Br J Dermatol 1973;88:475-479.
20. Plewig G, Jansen T. Seborrheic dermatitis. In: Wolf K, Goldsmith L, Katz SI, Glichrest BA, Paller AS, Lef-fell DJ, editors. Fitzpatrick's Dermatology in General Medicine. McGraw-Hill Companies, Inc.; 2008. pp. 219-225.
21. Kaszuba A, Schwartz RA, Seneczko F. Diagnosis, clinical types and treatment of psoriasis. Nowa Klinika 2001;8:762-768.
22. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol 1995;132:441-445.
23. Stratigos JD, Antoniou C, Katsambas A, Böhler K, Fritsch P, Schmöl A, et al. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis: a double-blind comparative study. J Am Acad Dermatol 1988;19:850-853.
24. Segal R, David M, Ingber A. Treatment with bi-fonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study. Acta Derm Venerol 1992;72:454-455.
25. Zienicke H, Korting HC, Braun-Falco O, Efendy I, Hagedorn M, Küchmeister B, et al. Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrheic dermatitis. Mycoses 1993;36:325-331.
26. Shemer A, Nathanson N, Kaplan B, Weiss G, Newman N, Trau H. Treatment of scalp seborr-heic dermatitis and psoriasis with and ointment of 40% urea and 1% bifonazole. Int J Dermatol 2000;39:521-538.
27. Faergemann J. Seborrhoeic dermatitis and Pityro-sporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole hydrocorti-sone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986;114:695-700.
28. Gupta AK, Bluhm R. Ciclopirox (Loprox) gel for su-perfcial fungal infections. Skin Ther Lett 2004;9:4-5.
29. Lorette G, Ermosilla V. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment. Eur J Der-matol 2006;6:558-564.
30. Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopiroxola-mine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatol Treat 2007;18:88-96.
31. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol 2011;4:32-38.
32. Ortonne J P, Lacour J P, Vitetta A, Le Fichoux Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrheic dermatitis in adults. Dermatology 1992;184:275-280.
33. Prasad D, Pandhi R, Negi KS, Kumar B. Topical met-ronidazole in seborrheic dermatitis - a double-blind study. Dermatology 2001;202:35-37.
34. Seckin D, Gurbuz O, Akin O. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study. J Eur Acad Dermatol Venereol 2007;21:345-350.
35. Koca R, Altinyazar HC, Eştürk E. Is topical metroni-dazole efective in seborrheic dermatitis? A double-blind study. Int J Dermatol 2003;42:632-635.
36. Cook BA, Warshaw EM. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. Am J Clin Dermatol 2009;10:105-116.
37. Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wen-ner RA, Bowers S, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol 2007;57:257-264.
38. Berk T, Scheinfeld N. Seborrheic dermatitis. P T 2010;35:348-352.
39. Opdyke DL, Burnett CM, Brauer EW. Anti-seborr-heic qualities of zinc pyrithione in a cream vehicle: II Safety evaluation. Food Cosmet Toxicol 1967;5:321-326.
40. Marks R, Pearse AD, Walker AP. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985;112:415-422.
41. Pierard-Franchimont C, Gofn V, Decroix J, Pierard GE. A multicenter randomized trial of ketoconazo-le 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol 2002;15:434-441.
42. Langtry JA, Rowland Payne CM, Staughton RC, Stewart JC, Horrobin DF. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis. Clin Exp Dermatol 1997;22:216-219.
43. Dreno B, Moyse D. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double blind study versus placebo. Eur J Dermatol 2002;12:549-552.
44. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double blind, placebo controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993;29:1008-1012.
45. Pirkhammer D, Seeber A, Hönigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an efective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000;143:964-968.
46. Vena GA, Micali G, Santoianni P, Cassano N, Peruz-zi E. Oral terbinafine in the treatment of multi-site seborrheic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol 2005;18:745-753.
47. Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fuconazole in the treatment of seborrheic dermatitis: a placebo controlled study. Am J Clin Dermatol 2007;8:235-238.
48. Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrheic dermatitis to ketoconazole. Br J Der-matol 1984;111:603-607.